Cerebrovascular accidents/ ischemic stroke. Therapeutic (nonsurgical) and rehabilitative physical medicine devices associated with adverse incidents
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with ischemic stroke were diagnosed according to WHO criteria Between 30 and 80 years old Within 6-12 months after stroke onset before enrollment Ability to walk without support or assistive device for at least 10 meters Adequate communication skills to understand and follow orders
Exclusion criteria
Exclusion criteria: Patients with Pregnancy Patients with an injury or cognitive disorder who cannot follow instructions and training Patients with Cardiac arrhythmias or a pacemaker Patients with Major vascular disease Patients with Impaired consciousness and mental disorders requiring drug therapy Patients with Severe visual impairments
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Non-linear measures of walking including the Lyapunov exponent and Floquet multipliers calculating local and orbital stability. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: Lyapunov exponent formula: y(i)= 1/?t Floquet multipliers formula: S_(k+1 )=F(S_k ).;User experience (UX) evaluated by applying the AttarkDiff questionnaire. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: User experience (UX) evaluated by applying the AttarkDiff questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The timed Up and Go test (TUG) to assess mobility in adults or predict their risk of falls. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: The timed Up and Go test (TUG), subjects are asked to rise from a standard armchair, walk to a marker 3 m away, turn, walk back, and sit down again.;The 6-Minute Walk Test. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: The 6-Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.;Assessing the virtual environment's effects on an individual's health. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: The Simulator Sickness Questionnaire.;Fear of falling. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: The Falls Efficacy Scale-International (FES-I).;Evaluating balance. Timepoint: All participants in the study will be measured before the start of the study, after the intervention (3 weeks later), and 2 months after the treatment. Method of measurement: The Berg Balance scale (BBS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences